News

05. A strange thing happened weeks before the Food and Drug Administration approved the first treatment made with CRISPR gene editing, an all-but cure for certain patients with sickle cell disease.
No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy. Experts weigh in on the path to profit for the treatment and the ...
The strategy uses a relatively recent genetic technique called CRISPR, which can make cuts in DNA to introduce errors into viral genetic material within immune cells. “These findings represent a ...
Scientists introduced CRISPR to the world as a gene-editing tool in summer 2012, when landmark papers from two independent groups demonstrated how the system could be wielded to make cuts in DNA.
Genome-editing tools such as zinc finger nucleases and TALENs (transcription activator-like effector nucleases) already existed, but Crispr proved to be far more efficient, not to mention easier ...
It’s been a monumental year for Crispr, the molecular tool scientists use to edit genetic material. This November, the United Kingdom authorized the first medical treatment using Crispr gene ...
She became the first sickle-cell patient to be treated with the gene-editing technology CRISPR—and one of the first humans to be treated with CRISPR, period. CRISPR at that point had been hugely ...
The CRISPR-like molecular scissors prevented extinction by guiding a copy of the transposon back to the location it jumped from, after cutting the DNA to slip the copy into place. "With this 'cut ...
The same might one day be said for the gene-editing technology known as CRISPR (clustered regularly interspaced short palindromic repeats). In a decade, scientists have transformed CRISPR from a ...